[Corrections] Correction to Lancet Oncol 2025; 26: 1443–53

Di Federico A, Stumpo S, Mantuano F, et al. Long-term overall survival with dual CTLA-4 and PD-L1 or PD-1 blockade and biomarker-based subgroup analyses in patients with advanced non-small-cell lung cancer: a systematic review and reconstructed individual patient data meta-analysis. Lancet Oncol 2025; 26: 1443–53—In figure 4A of this Article, the p value should have read p=0·20, and in figure 5A, the p value should have read p=0·012. These corrections have been made to the online version as of Nov 24, 2025.